Document is current
Any future updates will be listed below
-
Authors
George, Alexandra D.
Wang, Tingting
Duong, Thy
Schooneveldt, Yvette
Paul, Sudip
Olshansky, Gavriel
Mansell, Toby
Saffery, Richard
Vuillermin, Peter
Ponsonby, Anne-Louise
Burgner, David
,
Burugupalli, Satvika
Meikle, Peter J.
-
Funding
Funding for this research was provided by:
National Health and Medical Research Council
- License Information
-
More Information
Article History
Received: 23 July 2025
Accepted: 20 November 2025
First Online: 30 December 2025
Declarations
:
: PM declares a potential conflict of interest (PJM consults for Juvenescence Ltd, a biotech company that is developing a plasmalogen supplement product for market. The Baker Institute has a commercialization agreement with the Murdoch Children’s Research Institute relating to the development of infant formula products with plasmalogen precursor supplements. The Baker Institute holds several patents related to increasing plasmalogen levels for improved health outcomes. These have been licensed to Juvenescence Ltd). The remaining authors declare no conflict of interest.
